A Phase I, Single Ascending Dose, Safety and Pharmacokinetic Study of PN0621 in Healthy Volunteers

Phase 1

Recruiting

• Conditions: Inflammatory dieseases, Healthy Volunteers; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12607000275460
• Lead Sponsor: Peptech Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-05-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

BMI - Body mass Index' 19 to 29, nromal or clinically acceptable 'ECG - Electrocardiogram'

Exclusion Criteria

Donation or loss of more than 400ml blood within 3 months of study, history of infection, screen positive to Tuberculosis, Hepatitis C, Hepatisis B or Human immunodeficiency virus (HIV)

Study & Design

• Study Type: Interventional
• Study Design: Not specified